Mark Bamforth News Today

Kincell Bio, LLC (“Kincell”), a technology-forward contract development and manufacturing organization (CDMO) focused on cell therapies,...

RESIDENTS of Hebden were joined by a band of traditional Wassailers to bless the villages newly planted community orchard.

Pneumagen raises £8m to accelerate Phase 2 clinical development of Neumifil for the prevention & treatment of viral respiratory tract infectionsNeumifil is being developed for the prevention and treatment of virus induced exacerbations in patients with respiratory diseaseAdvancing Neumifil into a Phase 2b...

Clinical-stage diagnostics spin-out Dxcover has raised almost £10 million for its novel technology for early detection of multiple cancers, founded on research carried out at the University of Strathclyde. Click to read more...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Glasgow, Scotland-based startup Dxcover has raised $11.9 million in series A and grant financing to support the development of its liquid biopsy techn

Liquid biopsy technique aimed at early-stage cancer diagnosis via algorithmic analysis of infrared spectra.

MEMBERS of Grassington Players recently got together to celebrate the first meeting 100 years ago of their founders.

A GLASGOW-based company developing a blood test aimed at detecting cancer at an early stage has raised £9.7 million

Enables CE Marking of blood test for brain cancer and advances colorectal cancer development Dxcover Limited, a clinical-stage diagnostics company developing spectroscopic liquid biopsy technology